Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

181. Human Infection with a Novel Avian Influenza A(H5N6) Virus. Full Text available with Trip Pro

Human Infection with a Novel Avian Influenza A(H5N6) Virus. 26222578 2015 08 14 2016 11 25 1533-4406 373 5 2015 Jul 30 The New England journal of medicine N. Engl. J. Med. Human Infection with a Novel Avian Influenza A(H5N6) Virus. 487-9 10.1056/NEJMc1502983 Yang Zi-Feng ZF State Key Laboratory of Respiratory Disease, Guangzhou, China. Mok Chris K P CK Peiris Joseph S M JS Zhong Nan-Shan NS eng Case Reports Letter Research Support, Non-U.S. Gov't United States N Engl J Med 0255562 0028-4793 AIM (...) IM Animals China Humans Influenza A virus classification isolation & purification Influenza in Birds Influenza, Human diagnosis therapy virology Lung diagnostic imaging pathology Male Middle Aged Poultry Radiography 2015 7 30 6 0 2015 7 30 6 0 2015 8 15 6 0 ppublish 26222578 10.1056/NEJMc1502983

2015 NEJM

182. Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial. Full Text available with Trip Pro

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial. Human infections with the avian influenza A(H7N9) virus were first reported in China in 2013 and continue to occur. Hemagglutinin H7 administered alone is a poor immunogen necessitating evaluation of adjuvanted H7N9 vaccines.To evaluate the immunogenicity and safety of an inactivated H7N9 vaccine with and without AS03 adjuvant, as well as mixed (...)  = 96) (103.4 [95% CI, 78.7-135.9]; P < .001) but higher GMTs than 2 doses of MF59-adjuvanted formulation (n = 94) (29.0 [95% CI, 22.4-37.6]; P < .001).The AS03 and MF59 adjuvants augmented the immune responses to 2 doses of an inactivated H7N9 influenza vaccine, with AS03-adjuvanted formulations inducing the highest titers. This study of 2 adjuvants used in influenza vaccine formulations with adjuvant mixed on site provides immunogenicity information that may be informative to influenza pandemic

2015 JAMA Controlled trial quality: predicted high

183. Population-level susceptibility, severity and spread of pandemic influenza: design of, and initial results from, a pre-pandemic and hibernating pandemic phase study using cross-sectional data from the Health Survey for England (HSE) Full Text available with Trip Pro

Population-level susceptibility, severity and spread of pandemic influenza: design of, and initial results from, a pre-pandemic and hibernating pandemic phase study using cross-sectional data from the Health Survey for England (HSE) Population-level susceptibility, severity and spread of pandemic influenza: design of, and initial results from, a pre-pandemic and hibernating pandemic phase study using cross-sectional data from the Health Survey for England (HSE) Journals Library An error has

2015 NIHR HTA programme

184. Interventions effective in increasing influenza vaccination rates

Interventions effective in increasing influenza vaccination rates Interventions effective in increasing influenza vaccination rates | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Interventions effective in increasing influenza vaccination rates Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2015 Cochrane PEARLS

185. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation

Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial (...) . Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation. Health Technology Assessment 2015; 19(16) Authors' objectives To (1) evaluate whether or not low-dose corticosteroids given as an adjunct to standard treatment is beneficial in patients who are hospitalised with severe pandemic influenza and (2) develop an 'off-the-shelf' clinical trial that is ready to be activated

2015 Health Technology Assessment (HTA) Database.

186. Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic Full Text available with Trip Pro

Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find

2015 NIHR HTA programme

187. Fluenz Tetra - seasonal influenza in children

Fluenz Tetra - seasonal influenza in children FLUENZTETRA SUMMARY CT13920

2015 Haute Autorite de sante

188. Systematic review with meta analysis: Zanamivir for influenza in adults and children shows limited benefit for treatment of symptomatic influenza and no effect on relevant complications Full Text available with Trip Pro

Systematic review with meta analysis: Zanamivir for influenza in adults and children shows limited benefit for treatment of symptomatic influenza and no effect on relevant complications Zanamivir for influenza in adults and children shows limited benefit for treatment of symptomatic influenza and no effect on relevant complications | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your (...) browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Zanamivir for influenza in adults and children shows

2015 Evidence-Based Medicine

189. Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective

Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective Ting E, Ungar WJ Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been (...) made for the HTA database. Citation Ting E, Ungar WJ. Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective. Toronto, ON: Technology Assessment at SickKids (TASK). 2015 Authors' conclusions From the societal perspective and in many cases the health care system perspective as well, seasonal influenza vaccination was generally found to be a cost-effective strategy. Vaccinating all pregnant and postpartum women against seasonal influenza compared

2015 Health Technology Assessment (HTA) Database.

190. Systematic review of the cost-effectiveness of influenza immunization programs: A Canadian perspective

immunization programs and the inconsistencies that exist. Finally, specific research questions in addition to the primary and secondary research objectives conclude the section and state the purpose and need for this review. 1.1 Problem Statement Commonly referred to as “the flu,” influenza is an acute viral infection of the respiratory system, which causes annual epidemics that peak during November to March in countries that are located in the Northern Hemisphere such as Canada. Individuals infected (...) a universal influenza immunization program. 1.2 The Impact of Influenza Influenza, colloquially referred to as “the flu,” is highly contagious and easily transmissible. The virus can be transmitted from everyday personal contact such as hand-shaking, sneezing or coughing droplets, or through passing along the virus through fomites such as towels and door knobs (Centers for Disease Control and Prevention, 2013). Close proximity to infected birds and pigs can also be a point of exposure to other forms

2015 SickKids Reports

191. Use of neuraminidase inhibitors in influenza

Use of neuraminidase inhibitors in influenza Improving School Governance | 1 Use of neuraminidase inhibitors in influenza Image: Swine Flu virus Sculpture Luke Jerram/Wellcome Images October 2015 1 Use of Neuraminidase Inhibitors in Influenza Contents 1. Summary Background Commentary on the recent publications Pipeline of new drugs and resistance Research priorities Preparedness 3 2. Introduction Terms of reference and conduct of this review Current influenza guidelines 6 3. Studies considered (...) -prescribe-anti-virals-to-prevent-flu-for-nursing-home-patients/ [accessed 29 July 2015]. 20 McCartney M. Margaret McCartney: Don’t be bullied into prescribing Tamiflu. BMJ 2015;350. http://www.bmj.com/content/350/bmj.h417 [accessed 29 July 2015]. 10 3. Studies considered in this report In developing its conclusions, the steering group considered the following key studies that were published in 2014 and 2015: • Meta-analyses considering treatment and prophylaxis of seasonal influenza with neuraminidase

2015 Academy of Medical Sciences

192. The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST)

The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST) The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST). The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST). Rubin GJ, Bakhshi S, Amlôt R, Fear N, Potts HWW (...) , Michie S Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Rubin GJ, Bakhshi S, Amlôt R, Fear N, Potts HWW, Michie S. The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST). Health Services and Delivery Research 2014; 2(41) Authors' objectives During

2014 Health Technology Assessment (HTA) Database.

193. No evidence for benefits of influenza vaccine in institutional healthcare workers

No evidence for benefits of influenza vaccine in institutional healthcare workers No evidence for benefits of influenza vaccine in institutional healthcare workers | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms No evidence for benefits of influenza vaccine in institutional healthcare workers Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2014 Cochrane PEARLS

194. The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age

The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age Influenza is a serious problem for infants <6 months of age, whose hospitalization rates for influenza and associated illness are comparable with rates in the elderly. Because influenza vaccines are not effective in this age group, the optimal evidence-based strategy is to administer trivalent inactivated influenza vaccines during pregnancy. Immunizing with trivalent inactivated (...) influenza vaccines in the second and third trimester is well studied and safe, not only providing protection for the pregnant woman and her infant <6 months of age, but also for the fetus by decreasing the risk for low birth weight. Key Words: ALRI; Cocooning; Influenza; TIV

2014 Canadian Paediatric Society

195. Peramivir for acute uncomplicated influenza in adults

Peramivir for acute uncomplicated influenza in adults Peramivir for acute uncomplicated influenza in adults Peramivir for acute uncomplicated influenza in adults NIHR HSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSC. Peramivir for acute uncomplicated influenza in adults. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC (...) ). Horizon Scanning Review. 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Cyclopentanes; Guanidines; Influenza, Humans Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence NIHR Horizon Scanning Centre, School of Health&Population Sciences, University of Birmingham, Public Health building, Edgbaston, Birmingham, B15 2TT. Tel: +44 121 414 7831 Email: nihrhsc@contacts.bham.ac.uk

2014 Health Technology Assessment (HTA) Database.

196. Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial. Full Text available with Trip Pro

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial. Human infections with avian influenza A/H7N9 have resulted in high morbidity and mortality in China.To compare safety and immunogenicity of different doses of influenza A/Shanghai/2/13 (H7N9) vaccine mixed with or without the MF59 adjuvant.Multicenter, randomized, double-blind, phase 2 trial at 4 US sites enrolled 700 adults aged 19 to 64 years beginning (...) or both 15 µg doses (n = 34 [35%; 95% CI, 25%-45%] vs n = 47 [47%; 95% CI, 37%-58%], respectively; P = .10). Recent receipt of seasonal influenza vaccination and older age were associated with attenuated response. No vaccine-related serious adverse events occurred. Solicited postvaccination symptoms were generally mild with more local symptoms seen in participants who received the adjuvant.Point-of-use mixing and administration of 2 doses of H7N9 vaccine at the lowest tested antigen dose with MF59

2014 JAMA Controlled trial quality: predicted high

197. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial. Full Text available with Trip Pro

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial. The need to respond quickly to potential influenza pandemics is important. Immunologic priming (initial presentation of an antigen to allow antibody responses on revaccination) with vaccine directed toward an older avian influenza H5 strain might lead to secondary antibody responses to a single dose of more current H5 avian influenza vaccine.To assess priming with the older avian (...) influenza A/Vietnam/1203/2004(H5N1) (Vietnam) vaccine and to conduct dose-response studies with vaccine directed against the more contemporary H5N1 avian influenza virus, influenza A/Anhui/01/2005 (Anhui).Multicenter US randomized clinical trial beginning in June 2010 with follow-up continuing through October 2011 enrolling 72 healthy adults who were vaccinated 1 year previously with the Vietnam vaccine and 565 vaccine-naive adults.Participants who were previously vaccinated with 90 µg of unadjuvanted

2014 JAMA Controlled trial quality: predicted high

198. Fighting the flu

Fighting the flu Fighting the flu Fighting the flu Health Council of the Netherlands Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Council of the Netherlands. Fighting the flu. The Hague: Health Council of the Netherlands Gezondheidsraad (GR). 2014/16. 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Humans; Influenza (...) Vaccines; Influenza, Human; Netherlands Language Published English Country of organisation Netherlands English summary An English language summary is available. Address for correspondence Postbus 16052, 2500 BB Den Haag, The Netherlands. Tel: +31 70 340 7520;Fax: +31 70 340 7523 Email: info@gr.nl AccessionNumber 32014000945 Date abstract record published 30/07/2014 Health Technology Assessment (HTA) database Copyright © 2019 Health Council of the Netherlands Homepage Options Print PubMed record

2014 Health Technology Assessment (HTA) Database.

199. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-y

Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-y Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk (...) 18- to 64-year-olds Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds Nicholson KG, Abrams KR, Batham S, Medina MJ, Warren FC, Barer M, Bermingham A, Clark TW, Latimer N, Fraser M, Perera N, Rajakumar K, Zambon M Record Status This is a bibliographic record of a published health

2014 Health Technology Assessment (HTA) Database.

200. Intranasal influenza vaccine for children (Fluenz): it is better to keep to the injectable vaccine

Intranasal influenza vaccine for children (Fluenz): it is better to keep to the injectable vaccine Prescrire IN ENGLISH - Spotlight ''Intranasal influenza vaccine for children (Fluenz°): it is better to keep to the injectable vaccine'', 1 September 2013 {1} {1} {1} | | > > > Intranasal influenza vaccine for children (Fluenz°): it is better to keep to the injectable vaccine Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |    (...) |   |   |   |   |   |  Spotlight Intranasal influenza vaccine for children (Fluenz°): it is better to keep to the injectable vaccine In children where vaccination against influenza is advisable, the live attenuated influenza intranasal vaccine has not been evaluated in terms of influenza complications. It is better to keep to the injectable vaccine. Vaccination of children against influenza is offered when there is an increased risk of complications: severe

2014 Prescrire